Parker H. Petit’s commitment will launch a research hub focused on using artificial intelligence to model diseases, identify treatment paths, and move discoveries closer to patient care.

As artificial intelligence becomes more integrated into healthcare, researchers are exploring its potential to support clinical decision-making, improve mental health interventions, expand access to care, and accelerate medical innovation.

A Georgia Tech student transformed her search to understand her mother's ALS into AI-driven research that could reshape how scientists study neurodegenerative diseases.

A new Georgia Tech study shows a wireless wearable device could enable home-based monitoring of physiological changes associated with sleep and brain health.

While SpudCell is an important milestone in the field, it stops short of being a fully synthetic living cell.

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery.

Using artificial intelligence, the team is developing an edible vaccine that could protect birds from bird flu and reduce its spread to livestock and humans.

Georgia Tech researchers demonstrated the mechanics behind neural tube closure, which can lead to severe or fatal birth defects if unsuccessful.

Faculty at Georgia Tech use their expertise in engineering, math, and computer science to apply common principles of these disciplines to neuroscience research.

AI and machine learning provide new tools for scientists to think about drug discovery.